Vincerx Pharma Announces Formation of Scientific Advisory Board to Advance its Clinical Pipeline
News Provided By
Share This Article
/EIN News/ PALO ALTO, Calif., April 01, 2021 (GLOBE NEWSWIRE) Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced the formation of its Scientific Advisory Board (SAB) composed of world leading academics and industry leaders in cancer research and therapeutics. John C. Byrd, M.D., will serve as Chairman of the SAB.
“The Vincerx team is thrilled to welcome globally recognized key opinion leaders in hematologic malignancies and oncology drug development to our newly formed SAB,” said Ahmed Hamdy M.D., Chief Executive Officer of Vincerx. “Their collective expertise aligns with the advancement of our diversified oncology pipeline and will be critical as we expand our research and development efforts and p
(The Center Square) â Rep. Jim Banks, R-Ind., sent a letter to President Joe Biden this week asking him to explain why he reportedly used a tax loophole to avoid paying $500,000 in payroll taxes.
In a letter written this week, Banks, who serves as Republican Study Committee chairman, asked Biden, âDo you intend to undo your hypocrisy and pay these funds back to the American people?â
Banks said that $13 million worth of income redirected into two S-corporations enabled Biden to avoid paying personal income taxes by directing revenue from book royalties and speaking appearances and not paying self-employment payroll tax liabilities that would have funded Medicare and other federal programs.
`따상` 입성 SK바이오사이언스, 지금 팔아? 6월까지 기다려? mk.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mk.co.kr Daily Mail and Mail on Sunday newspapers.